Disposal Group, Including Discontinued Operation, Consideration, Royalty Percentage

No definition available.

Name:	bhc_DisposalGroupIncludingDiscontinuedOperationConsiderationRoyaltyPercentage
Namespace Prefix:	bhc_
Data Type:	num:percentItemType
Balance Type:	na
Period Type:	duration

- Definition

Disposal Group, Number Of Products For Disposal

+ References

No definition available.

+ Details

Name:	bhc_DisposalGroupNumberOfProductsForDisposal
Namespace Prefix:	bhc_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	instant

- Definition

Loans And Leases Receivable, Term

+ References

No definition available.

+ Details

Name:	bhc_LoansAndLeasesReceivableTerm
Namespace Prefix:	bhc_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

- Definition

Number Of Divestitures

+ References

No definition available.

+ Details

Name:	bhc_NumberOfDivestitures
Namespace Prefix:	bhc_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	duration

- Definition

Amount of revenue attributable to disposal group, including, but not limited to, discontinued operation.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 5B
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760

+ Details

Name:	us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Amount of gain (loss) from sale and disposal of integrated set of activities and assets capable of being conducted and managed for purpose of providing return in form of dividend, lower cost, or other economic benefit to investor, owner, member and participant.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3602-108585

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 1B
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=109239629&loc=SL4582445-111684

+ Details

Name:	us-gaap_GainLossOnSaleOfBusiness
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of a finite-lived intangible asset to fair value.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3602-108585

Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 50
-Paragraph 3
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275

+ Details

Name:	us-gaap_ImpairmentOfIntangibleAssetsFinitelived
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

The aggregate amount of write-downs for impairments recognized during the period for long-lived assets held for abandonment, exchange or sale.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3602-108585

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 360
-SubTopic 10
-Section 45
-Paragraph 15
-URI http://asc.fasb.org/extlink&oid=109226348&loc=d3e2611-110228

+ Details

Name:	us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

No definition available.

+ Details

Name:	us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

For an unclassified balance sheet, reflects the carrying amount of unpaid loan amounts due from related parties at the balance sheet date.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 850
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03.7(e))
-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878

+ Details

Name:	us-gaap_LoansAndLeasesReceivableRelatedParties
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

- Definition

The number of countries in which the entity operates as of balance sheet date.

+ References

No definition available.

+ Details

Name:	us-gaap_NumberOfCountriesInWhichEntityOperates
Namespace Prefix:	us-gaap_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	instant

- Definition

The cash inflow associated with the amount received from the sale of a portion of the company's business, for example a segment, division, branch or other business, during the period.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 12
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3179-108585

+ Details

Name:	us-gaap_ProceedsFromDivestitureOfBusinesses
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Minimum amount of purchase arrangement in which the entity has agreed to expend funds to procure goods or services from a supplier.

+ References

No definition available.

+ Details

Name:	us-gaap_PurchaseObligation
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Details

Name:	us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=bhc_CertainProductsForDisposalSeptemberTwoThousandNineteenMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=bhc_CeraVeAcneFreeAMBISkincareBrandMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=bhc_DendreonPharmaceuticalsLLCMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=bhc_INovaPharmaceuticalsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=bhc_ObagiMedicalProductsInc.Member
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=bhc_SproutPharmaceuticalsInc.Member
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_RangeAxis=srt_MinimumMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_ProductOrServiceAxis=bhc_DiversifiedProductsSegmentMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

DIVESTITURES - Narrative (Details) divestiture in Millions, $ in Millions						7 Months Ended	12 Months Ended
	Dec. 20, 2017 USD ($)	Nov. 09, 2017 USD ($)	Sep. 29, 2017 USD ($)	Jun. 28, 2017 USD ($)	Mar. 03, 2017 USD ($)	Nov. 08, 2017 USD ($)	Dec. 31, 2019 USD ($) country product	Dec. 31, 2018 USD ($) divestiture	Dec. 31, 2017 USD ($)
Asset acquisitions and disposition
Number of material divestitures \| divestiture								0
Impairment write-down							$ 8
Number of countries in which entity operates (more than) \| country							100
Impairment of finite-lived intangible assets							$ 5
Held For Sale
Asset acquisitions and disposition
Impairment write-down								$ 5	$ 114
Certain Products For Disposal, September 2019 \| Held For Sale
Asset acquisitions and disposition
Disposal group, revenue							14	19
Impairment write-down							8
CeraVe, AcneFree, AMBI Skincare Brand
Asset acquisitions and disposition
Gain (loss) on sale of business							0	0	309
CeraVe, AcneFree, AMBI Skincare Brand \| Held For Sale
Asset acquisitions and disposition
Net cash proceeds					$ 1,300
Gain (loss) on sale of business									309
Dendreon
Asset acquisitions and disposition
Gain (loss) on sale of business							0	0	97
Dendreon \| Held For Sale
Asset acquisitions and disposition
Net cash proceeds				$ 845
Gain (loss) on sale of business									97
iNova
Asset acquisitions and disposition
Gain (loss) on sale of business							$ 0	0	309
iNova \| Held For Sale
Asset acquisitions and disposition
Net cash proceeds			$ 938
Gain (loss) on sale of business									309
Number of countries in which entity operates (more than) \| country							15
Obagi Medical Products, Inc. \| Held For Sale
Asset acquisitions and disposition
Impairment of finite-lived intangible assets						$ 103
Obagi Medical Products, Inc. \| Disposal Group, Disposed of by Sale, Not Discontinued Operations
Asset acquisitions and disposition
Net cash proceeds		$ 190
Gain (loss) on sale of business									(13)
Sprout
Asset acquisitions and disposition
Gain (loss) on sale of business							$ 0	$ 0	(98)
Loan term	5 years
Related party loan	$ 25
Sprout \| Minimum
Asset acquisitions and disposition
Purchase obligation (no less than)	$ 200
Sprout \| Held For Sale
Asset acquisitions and disposition
Impairment write-down									351
Sprout \| Disposal Group, Disposed of by Sale, Not Discontinued Operations
Asset acquisitions and disposition
Gain (loss) on sale of business									$ (98)
Royalty percentage	6.00%
Diversified Products \| Certain Products For Disposal, September 2019 \| Held For Sale
Asset acquisitions and disposition
Number of products for disposal \| product							1